Enzo Biochem/ENZ

$1.38

2.22%
-
1D1W1MYTD1YMAX

About Enzo Biochem

Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.
Ticker
ENZ
Sector
Healthcare
Trading on
NYSE
Industry
Biotechnology & Drugs
CEO
Kara Cannon
Employees
179
Headquarters
Farmingdale, United States

Enzo Biochem Metrics

BasicAdvanced
$69.68M
Market cap
2.76
P/E ratio
$0.50
EPS
0.76
Beta
-
Dividend rate

Enzo Biochem Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-84.61% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$7.8M
-74.84%
Net income
$-6.6M
-132.67%
Profit margin
-84.61%
-229.85%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Enzo Biochem stock

Buy or sell Enzo Biochem stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing